magnesium sulfate has been researched along with Developmental Disabilities in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashwood, P; Crowther, CA; Haslam, R; Middleton, PF; Wilkinson, D | 1 |
| Manuck, TA; Sheng, X; Varner, MW; Yoder, BA | 1 |
| Caritis, SN; Carpenter, M; Dudley, DJ; Hankins, GD; Iams, JD; Jablonski, KA; Leveno, KJ; Malone, FD; Marshall, NE; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Reddy, UM; Rouse, DJ; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
| Kabbouche, M; Khoury, CK | 1 |
| Dotters-Katz, SK; Manuck, TA; Metz, TD; Smid, MC | 1 |
| Crowther, CA; Doyle, LW; Haslam, RR; Hiller, JE | 1 |
| Bénichou, J; Marpeau, L; Marret, S | 1 |
1 review(s) available for magnesium sulfate and Developmental Disabilities
| Article | Year |
|---|---|
Management of Primary Headache in the Emergency Department and Inpatient Headache Unit.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Developmental Disabilities; Dihydroergotamine; Disease Management; Emergency Service, Hospital; Headache; Humans; Inpatients; Magnesium Sulfate; Tryptamines | 2016 |
6 trial(s) available for magnesium sulfate and Developmental Disabilities
| Article | Year |
|---|---|
Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
Topics: Blindness; Calcium Channel Blockers; Cerebral Palsy; Child Behavior; Child, Preschool; Deafness; Developmental Disabilities; Female; Gestational Age; Health Status; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Perinatal Mortality; Pregnancy; Premature Birth; Psychological Tests; Research Design; Stillbirth | 2013 |
Correlation between initial neonatal and early childhood outcomes following preterm birth.
Topics: Adult; Cerebral Palsy; Developmental Disabilities; Female; Health Status Indicators; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Premature Birth; Risk Factors; ROC Curve; Twins; Young Adult | 2014 |
The association of cord serum cytokines with neurodevelopmental outcomes.
Topics: Adult; Case-Control Studies; Cerebral Palsy; Child Development; Child, Preschool; Cytokines; Developmental Disabilities; Female; Fetal Blood; Humans; Infant; Infant, Newborn; Infant, Premature; Interleukin-1beta; Interleukin-8; Logistic Models; Magnesium Sulfate; Pregnancy; Premature Birth; Prognosis; Tocolytic Agents; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana.
Topics: Cannabis; Cerebral Palsy; Child Development; Child, Preschool; Developmental Disabilities; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Male; Marijuana Abuse; Morbidity; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Factors | 2017 |
Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Topics: Cerebral Palsy; Developmental Disabilities; Female; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk | 2003 |
Benefit of magnesium sulfate given before very preterm birth to protect infant brain.
Topics: Brain Diseases; Delivery, Obstetric; Developmental Disabilities; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Infusions, Intravenous; Magnesium Sulfate; Male; Odds Ratio; Pregnancy; Premature Birth; Probability; Reference Values; Survival Analysis; Treatment Outcome | 2008 |